GUERBET (GBT.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:GBT - FR0000032526 - Common Stock
14.8 EUR
+0.2 (+1.37%)
GBT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 68 industry peers in the Health Care Equipment & Supplies industry. The financial health of GBT is average, but there are quite some concerns on its profitability. GBT is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year GBT was profitable.
GBT had a positive operating cash flow in the past year.
Of the past 5 years GBT 4 years were profitable.
Each year in the past 5 years GBT had a positive operating cash flow.
1.2 Ratios
GBT has a Return On Assets of 0.76%. This is in the lower half of the industry: GBT underperforms 61.76% of its industry peers.
With a Return On Equity value of 2.06%, GBT is not doing good in the industry: 61.76% of the companies in the same industry are doing better.
GBT has a worse Return On Invested Capital (3.15%) than 66.18% of its industry peers.
GBT had an Average Return On Invested Capital over the past 3 years of 4.08%. This is significantly below the industry average of 9.73%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 2.06% | ||
| ROIC | 3.15% |
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
1.3 Margins
Looking at the Profit Margin, with a value of 0.96%, GBT is doing worse than 61.76% of the companies in the same industry.
GBT's Profit Margin has declined in the last couple of years.
GBT's Operating Margin of 4.19% is on the low side compared to the rest of the industry. GBT is outperformed by 66.18% of its industry peers.
GBT's Operating Margin has declined in the last couple of years.
The Gross Margin of GBT (78.03%) is better than 91.18% of its industry peers.
In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.19% | ||
| PM (TTM) | 0.96% | ||
| GM | 78.03% |
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GBT is destroying value.
Compared to 1 year ago, GBT has about the same amount of shares outstanding.
GBT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, GBT has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.07 indicates that GBT is not a great score, but indicates only limited risk for bankruptcy at the moment.
GBT has a Altman-Z score (2.07) which is comparable to the rest of the industry.
The Debt to FCF ratio of GBT is 8.94, which is on the high side as it means it would take GBT, 8.94 years of fcf income to pay off all of its debts.
GBT has a Debt to FCF ratio (8.94) which is in line with its industry peers.
A Debt/Equity ratio of 0.93 indicates that GBT is somewhat dependend on debt financing.
GBT has a worse Debt to Equity ratio (0.93) than 77.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.93 | ||
| Debt/FCF | 8.94 | ||
| Altman-Z | 2.07 |
ROIC/WACC0.47
WACC6.68%
2.3 Liquidity
GBT has a Current Ratio of 2.32. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.32, GBT is doing good in the industry, outperforming 67.65% of the companies in the same industry.
GBT has a Quick Ratio of 1.03. This is a normal value and indicates that GBT is financially healthy and should not expect problems in meeting its short term obligations.
GBT has a Quick ratio (1.03) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
GBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -77.27%.
Measured over the past years, GBT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.50% on average per year.
Looking at the last year, GBT shows a decrease in Revenue. The Revenue has decreased by -2.01% in the last year.
GBT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.59% yearly.
EPS 1Y (TTM)-77.27%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
3.2 Future
GBT is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.56% yearly.
GBT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.86% yearly.
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue Next Year-4.68%
Revenue Next 2Y-1.34%
Revenue Next 3Y0.3%
Revenue Next 5Y3.86%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 24.67, GBT is valued on the expensive side.
GBT's Price/Earnings ratio is a bit cheaper when compared to the industry. GBT is cheaper than 70.59% of the companies in the same industry.
GBT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.13 indicates a reasonable valuation of GBT.
Based on the Price/Forward Earnings ratio, GBT is valued cheaply inside the industry as 91.18% of the companies are valued more expensively.
GBT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.67 | ||
| Fwd PE | 10.13 |
4.2 Price Multiples
95.59% of the companies in the same industry are more expensive than GBT, based on the Enterprise Value to EBITDA ratio.
100.00% of the companies in the same industry are more expensive than GBT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.2 | ||
| EV/EBITDA | 4 |
4.3 Compensation for Growth
GBT's earnings are expected to decrease with -10.60% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
5. Dividend
5.1 Amount
GBT has a Yearly Dividend Yield of 2.69%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.13, GBT pays a better dividend. On top of this GBT pays more dividend than 86.76% of the companies listed in the same industry.
GBT's Dividend Yield is a higher than the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
5.2 History
The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
GBT pays out 81.59% of its income as dividend. This is not a sustainable payout ratio.
GBT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP81.59%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPA:GBT (1/9/2026, 7:00:00 PM)
14.8
+0.2 (+1.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.22%
Inst Owner ChangeN/A
Ins Owners5.01%
Ins Owner ChangeN/A
Market Cap187.07M
Revenue(TTM)809.67M
Net Income(TTM)7.73M
Analysts44
Price Target15.56 (5.14%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP81.59%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.9%
Revenue NY rev (3m)-1.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.67 | ||
| Fwd PE | 10.13 | ||
| P/S | 0.23 | ||
| P/FCF | 4.2 | ||
| P/OCF | 2 | ||
| P/B | 0.5 | ||
| P/tB | 0.68 | ||
| EV/EBITDA | 4 |
EPS(TTM)0.6
EY4.05%
EPS(NY)1.46
Fwd EY9.87%
FCF(TTM)3.53
FCFY23.83%
OCF(TTM)7.4
OCFY50.01%
SpS64.06
BVpS29.76
TBVpS21.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 2.06% | ||
| ROCE | 4.45% | ||
| ROIC | 3.15% | ||
| ROICexc | 3.64% | ||
| ROICexgc | 4.3% | ||
| OM | 4.19% | ||
| PM (TTM) | 0.96% | ||
| GM | 78.03% | ||
| FCFM | 5.51% |
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexgc growth 3Y-4.82%
ROICexgc growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.93 | ||
| Debt/FCF | 8.94 | ||
| Debt/EBITDA | 3.27 | ||
| Cap/Depr | 66.71% | ||
| Cap/Sales | 6.05% | ||
| Interest Coverage | 1.56 | ||
| Cash Conversion | 87.13% | ||
| Profit Quality | 576.4% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.07 |
F-Score5
WACC6.68%
ROIC/WACC0.47
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.27%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
Revenue Next Year-4.68%
Revenue Next 2Y-1.34%
Revenue Next 3Y0.3%
Revenue Next 5Y3.86%
EBIT growth 1Y-42.07%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year50.63%
EBIT Next 3Y21.02%
EBIT Next 5Y21.78%
FCF growth 1Y182.18%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y2940.2%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%
GUERBET / GBT.PA FAQ
What is the fundamental rating for GBT stock?
ChartMill assigns a fundamental rating of 4 / 10 to GBT.PA.
What is the valuation status of GUERBET (GBT.PA) stock?
ChartMill assigns a valuation rating of 5 / 10 to GUERBET (GBT.PA). This can be considered as Fairly Valued.
How profitable is GUERBET (GBT.PA) stock?
GUERBET (GBT.PA) has a profitability rating of 3 / 10.
What is the financial health of GUERBET (GBT.PA) stock?
The financial health rating of GUERBET (GBT.PA) is 4 / 10.
Is the dividend of GUERBET sustainable?
The dividend rating of GUERBET (GBT.PA) is 4 / 10 and the dividend payout ratio is 81.59%.